Department of General Surgery, Lan Zhou University Second Hospital, Lanzhou, China.
Department of Medical Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Ann Surg Oncol. 2020 May;27(5):1480-1487. doi: 10.1245/s10434-019-08098-w. Epub 2019 Nov 27.
This study evaluated the additional value of lymph node ratio (LNR) when used in combination with the 8th American Joint Committee on Cancer (AJCC) staging system for gastric cancer (GC) to establish a new LNR-based AJCC (rAJCC) staging system.
We searched the Surveillance, Epidemiology, and End Results database to identify patients who had undergone surgery to resect nonmetastatic GC during the period from 2004 to 2013. Recursive partitioning analysis was used to identify the optimal cutoff points for LNR, and an LNR-based N classification system was designed accordingly. The two staging systems were compared in terms of discriminatory ability, as measured by the concordance index. The likelihood ratio Chi square test was used to assess prognostic homogeneity.
A total of 13,027 patients were included in the final analysis. All of the included patients, who belonged to the 8th AJCC IIIA category, could be further classified into the rIIB, rIIIA, rIIIB, and rIIIC subgroups using the proposed rAJCC classification system. A difference in 5-year overall survival rate was found between patients classified as having rIIA disease and those classified as having rIIIC disease (66.7% vs. 5.1%). The rAJCC staging system was superior to the 8th AJCC staging system in terms of discriminatory capacity and prognostic homogeneity.
A new rAJCC staging system is proposed, with prognostic superiority to the 8th AJCC staging system for patients with GC. The rAJCC staging system may serve as a useful tool in clinical practice.
本研究评估了淋巴结比率(LNR)与第 8 版美国癌症联合委员会(AJCC)胃癌(GC)分期系统联合应用时的附加价值,旨在建立一种新的基于 LNR 的 AJCC(rAJCC)分期系统。
我们在 Surveillance, Epidemiology, and End Results 数据库中检索了 2004 年至 2013 年间接受非转移性 GC 手术切除的患者。采用递归分区分析确定 LNR 的最佳截断点,并相应设计基于 LNR 的 N 分类系统。通过一致性指数评估两种分期系统的判别能力,采用似然比卡方检验评估预后同质性。
共纳入 13027 例患者进行最终分析。所有纳入的患者均属于第 8 版 AJCC IIIA 期,可根据提出的 rAJCC 分类系统进一步分为 rIIB、rIIIA、rIIIB 和 rIIIC 亚组。rIIA 疾病患者和 rIIIC 疾病患者的 5 年总生存率存在差异(66.7% vs. 5.1%)。rAJCC 分期系统在判别能力和预后同质性方面优于第 8 版 AJCC 分期系统。
提出了一种新的 rAJCC 分期系统,与第 8 版 AJCC 分期系统相比,该系统对 GC 患者具有更好的预后预测能力。rAJCC 分期系统可能成为临床实践中的有用工具。